Exciting news!
Congrats to Dr. Laga & Dr. Solomon for publishing their work on using 16S rRNA in situ hybridization to detect Gram-pos and Gram-neg bacteria in brain abscesses, marking an important step in bacterial detection in neurological infections!
https://t.co/PFzVOgTtZb
🎉 Congrats to Drs. Keith Ligon and Sandro Santagata on their recently published paper! Their work offers exciting insights into mechanisms of response and resistance to Navtemadlin in GBM patients.
https://t.co/vW99lnDnpk #neuropath#pathology#ResearchExcellence
Congratulations to Dr. Yu on this groundbreaking work in Digital Pathology! Featuring contributions from our own faculty, @NeuropathDM and @KeithLigon5.
Exciting news! Consensus update on integration of molecular features for Meningioma grading. Featuring contribution from @SantagataLab.
cIMPACT-NOW Update 8: Clarifications on molecular risk parameters and recommendations for WHO grading of meningiomas https://t.co/aejevSgwYQ
#BreakingNews@US_FDA has approved Vorasidenib for patients with Grade 2 gliomas with IDH1 or IDH2 mutations. Congratulations Dr. Patrick Wen and to all the patients on this incredible advancement! https://t.co/6PtuHuwZr2
Wonderful time at the Longwood Neuropathology Training Program reception at the #AANP2024 conference! Alumni, faculty, and friends gathered in beautiful Lake Tahoe. Here's to a weekend of learning, networking, and celebrating a century of advancements in Neuropathology! @BWHPath
Outstanding Workshop on Digital Pathology Imaging in Cancer Clinical Trials and Research coming up March 6th-7th! Our own Dr. Sandro Santagata @SantagataLab will be speaking, as well as long-time divisional collaborator @kunhsingyu! #neuro#pathology
https://t.co/Z7Hqx8wd2T
Targeted therapy leads to dramatic responses across all treated patients in phase 2 clinical trial of rare brain tumor papillary craniopharyngioma--an amazing paper by @SantagataLab! #neuropath#braintumor#BWHPath
https://t.co/UC8eGJw1xr
Congrats to new paper out in preprint by @BWHNeuropath faculty Dr. Matthew Torre and Mel Feany on A Drosophila model of chemotherapy-related cognitive impairment https://t.co/HhlyJjBXtZ
Early-stage investigators proposed innovative high-impact research ideas for the @NIHDirector’s New Innovator Award. See the projects the awardees will pursue: https://t.co/ujuDoPPjK2 #NIHHighRisk
Congratulations to Sam Naik in my lab for his first contribution as an author on a scientific research paper! Very proud of him and excited for his next phase in medical school! Great to collaborate with @SizunJ https://t.co/oPuxzzQZLm
We have a tenure track position open in the Department of Path at UCI - please rt! If you are focused on research in Neurodegeneration we'd love to see you apply 🧠🧠 #neuropath#PathTwitter https://t.co/1drnU191jR @horo
Excited to be in Monterey for #neuropath2023! Can’t wait to see friends and colleagues from all over the country and world! Also looking forward to meeting new #neuropath people. #AANP2023@neuropathology
Dr. Samuels was an unqualified lover of #neuropathology and key to the training and success of so many in our Neuropathology program. Eternal gratitude to him. His legacy will live on through the education, mentoring, and stories he gave to all of us.
We are shocked and saddened at the loss of Dr. Martin Samuels. A platform will be available tomorrow afternoon for faculty and trainees to share tributes and memories of Marty via Zoom. @harvardneuromds